Kanso Diagnostics

Kanso’s proprietary “Molecular 2-Factor Authentication” platform combines isothermal amplification with a unique molecular labeling reaction, delivering lab-grade sensitivity, high specificity, multiplexing, and point mutation detection for antimicrobial resistance. A microfluidics-free design simplifies manufacturing and reduces cost, while a compact, plug-and-play system enables same-visit results in the doctor’s office with no setup fee. By shifting testing revenue from central labs to care providers, Kanso aims to create a compelling financial incentive for adoption alongside better patient care. Clinical validation on patient samples has already demonstrated robust performance, with our vision to transform women’s health starting with STIs and expanding to vaginitis and beyond.